Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Curr Drug Targets ; 19(10): 1127-1147, 2018.
Article in English | MEDLINE | ID: mdl-28891455

ABSTRACT

BACKGROUND: Particulate matter directly emitted into the air by sources such as combustion processes and windblown dust, or formed in the atmosphere by transformation of emitted gases are the major contributors to air pollution that triggers a diverse array of human pathologies including lung cancer. The mortality in lung cancer is usually high as the disease is not symptomatic at its early treatable stage. Moreover, available methods for screening are costly and mainly rely on imaging techniques which lack sufficient sensitivity and specificity. Despite progress in the identification of biomarkers, gene mutation based approaches still face formidable challenges as the disease evolves from a complex interplay between environment and host. Therefore, identification of an epigenomic signature might be useful for early diagnosis with the potential to reduce the environmental-associated disease burden. OBJECTIVE: The review discusses the utility of epigenomic signature in identification and management of the environmental-associated lung cancers. CONCLUSION: Non-invasive 'liquid biopsy' based epigenomic screening has recently emerged as a methodology which has potential to characterize tumor heterogeneity at initial stages. Epigenetic signatures (methylated DNA, miRNA, and post transcriptionally modified histones) known to reflect the vital cellular changes, circulate at higher levels in the individuals with lung cancer. These circulating biological entities are reported to be closely associated with the clinical outcome of lung cancer patients and thus strongly stand as the probable candidate to identify disease at an early stage and monitor treatment response, thereby, benefiting patients and improving their lives. However, for effective implementation of the strategy as "point-of-care" test for screening population-at-risk will require exhaustive clinical validation.


Subject(s)
Biomarkers, Tumor/genetics , Epigenesis, Genetic , Inhalation Exposure/adverse effects , Lung Neoplasms/genetics , Particulate Matter/adverse effects , Animals , Biomarkers, Tumor/blood , Circulating MicroRNA/blood , Circulating MicroRNA/genetics , DNA Methylation , Early Detection of Cancer/methods , Gene Expression Profiling , Genetic Predisposition to Disease , Histones/metabolism , Humans , Liquid Biopsy , Lung Neoplasms/blood , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Phenotype , Prognosis , Protein Processing, Post-Translational , Risk Assessment , Risk Factors , Transcriptome
2.
Curr Pharm Des ; 23(8): 1175-1187, 2017.
Article in English | MEDLINE | ID: mdl-27817745

ABSTRACT

The burden of cardio-vascular and other age-related non-communicable diseases are rapidly increasing worldwide. Majority of these chronic ailments are curable, if diagnosed at early stages. Candidate biomarkers of early detection are therefore essential for identification of high-risk individuals, prompt and accurate disease diagnosis, and to monitor therapeutic response. The functional significance of circulating nucleic acids that recapitulate specific disease profiles is now well established. But subtle changes in DNA sequence may not solely reflect the differentiation of gene expression patterns observed in diverse set of diseases as epigenetic phenomena play a larger role in aetiology and patho-physiology. Unlike genetic markers, knowledge about the diagnostic utility of circulating epigenetic signatures: methylated DNA; micro RNA and modified histones are deficient. Characterization of these novel entities through omics-based molecular technologies might prompt development of a range of laboratory-based strategies, thereby accelerating their broader translational purpose for early disease diagnosis, monitoring therapeutic response and drug resistance. However, largest opportunity for innovation lies in developing point-of-care tests with accurate diagnostic and higher prognostic score that is applicable for screening of high-risk populations.


Subject(s)
Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , Epigenesis, Genetic , Epigenomics , Age Factors , Biomarkers/blood , Cardiovascular Diseases/diagnosis , Chronic Disease , Humans
3.
Parasit Vectors ; 7: 235, 2014 May 20.
Article in English | MEDLINE | ID: mdl-24886293

ABSTRACT

BACKGROUND: In recent years, it has been well documented that gut flora not only influence mosquito physiology, but also significantly alter vector competency. Although, salivary gland and gut constitute key partners of the digestive system, it is still believed that salivary glands may harbor less flora than gut (Parasit Vectors 6: 146, 2013). METHODS: Using a metagenomic approach, we have identified for the first time the diverse microbial community associated with these two physiologically different tissues of the digestive system in the mosquito Anopheles culicifacies. RESULTS: A total of 17 different phyla could be assigned to the whole metagenomic dataset, predominated by the phylum Proteobacteria, Firmicutes, Bacteriodetes, Tenericutes and Actinomycetes. Common bacteria included the members of Enhydrobacter, Agromonas, Serratia, Ralsonia, Lactobacillus, Pseudomonas, Streptococcus, Rubrobacter, Anaerococcus, Methylobacterium, Turicibacter, Elizabethkingia etc. in both the tissues representing 'core microbiota' of the mosquito digestive system. Salivary associated unique bacterial community included the members of Chloriflexi, Chlorobi, Cyanobacteria, Nitrospira, TM7, Armatimonadetes, Planctomycetes, Fibrobacteres etc. CONCLUSION: We find that the salivary gland microbial community structure is more diverse than gut of the mosquito, probably due to differential feeding associated engagements such as food acquisition, ingestion and digestion processes.


Subject(s)
Anopheles/classification , Anopheles/microbiology , Bacteria/classification , Bacteria/isolation & purification , Gastrointestinal Tract/microbiology , Salivary Glands/microbiology , Animals , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Female , Gene Expression Regulation, Bacterial , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics
SELECTION OF CITATIONS
SEARCH DETAIL